- Exchange: Johannesburg
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Adcock Ingram Holdings Ltd
+ Add to WatchlistAIP:SJ
6,875.00 ZAr 60.00 0.88%As of 11:00:10 ET on 05/17/2013.
Snapshot for Adcock Ingram Holdings Ltd (AIP)
| Open: | 6,850.00 | Day's Range: | 6,820.00 - 6,950.00 | Volume: | 1,407,016 |
|---|---|---|---|---|---|
| Previous Close: | 6,815.00 | 52wk Range: | 5,100.00 - 6,950.00 | 1-Yr Rtn: | +12.71% |
Key Statistics for AIP
| Current P/E Ratio (ttm) | 16.2760 |
|---|---|
| Estimated P/E(09/2013) | 16.1082 |
| Relative P/E vs. JALSH | 0.9000 |
| Earnings Per Share (ZAR) (ttm) | 4.2240 |
| Est. EPS (ZAR) (09/2013) | 4.2680 |
| Est. PEG Ratio | 1.7958 |
| Market Cap (M ZAR) | 12,042.06 |
| Shares Outstanding (M) | 175.16 |
| 30 Day Average Volume | 1,411,591 |
| Price/Book (mrq) | 3.3888 |
| Price/Sale (ttm) | 2.5246 |
| Dividend Indicated Gross Yield | 2.92% |
| Cash Dividend (ZAr) | 115.0000 |
| Last Dividend | 01/07/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/29/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AIP
Company Profile & Key Executives for AIP
Adcock Ingram Holdings Limited is a pharmaceutical company. The Company offers a range of generics and prescription medicines across various therapeutic classes.
| Jonathan James LouwCEO/Managing Director | Andrew Gideon Hall "Andy"Deputy CEO/Finance Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AIP News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page